Amylyx Pharmaceuticals, Inc. - stock earnings
AMLX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 4.7 million USD | 108.4 million USD |
| 2023Q3 | 20.9 million USD | 102.7 million USD |
| 2023Q2 | 22.1 million USD | 98.2 million USD |
| 2023Q1 | 1.6 million USD | 71.4 million USD |
| 2022Q4 | -42.7 million USD | 21.9 million USD |
| 2022Q3 | -53.8 million USD | 345000 USD |
| 2022Q2 | -54.1 million USD | ? USD |
| 2022Q1 | -47.8 million USD | ? USD |
| 2021Q4 | -28.3 million USD | ? USD |
| 2021Q3 | -23.1 million USD | 285000 USD |
| 2021Q2 | -21.9 million USD | ? USD |
| 2021Q1 | -14.5 million USD | ? USD |
| 2020Q4 | -8.6 million USD | 350000 USD |
AMLX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 49.3 million USD | 380.8 million USD |
| 2022 | -198.4 million USD | 22.2 million USD |
| 2021 | -87.9 million USD | 285000 USD |
| 2020 | -44.8 million USD | 650000 USD |
| 2019 | -14.8 million USD | 1.4 million USD |
AMLX
Price: $1.93
52 week price:
Earnings Per Share: 0.70 USD
P/E Ratio: 1614
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 390250
Market Capitalization: 182.7 million